Com­pe­ti­tion en­force­ment led to fair­er prices, in­no­v­a­tive prod­ucts — EC re­port

An­titrust and merg­er en­force­ment in Eu­rope has led to fair­er prices for med­i­cines and kept mar­kets com­pet­i­tive over the past sev­er­al years, ac­cord­ing to a re­port the Eu­ro­pean Com­mis­sion pub­lished Fri­day.

The 58-page re­port, which an­a­lyzed en­force­ment ac­tions by the EC and mem­ber states’ na­tion­al com­pe­ti­tion au­thor­i­ties be­tween 2018 and 2022, found that en­force­ment ac­tions ul­ti­mate­ly led to a stronger phar­ma­ceu­ti­cal mar­ket and en­hanced ac­cess to med­ica­tions. The re­port comes as US reg­u­la­tors have tak­en a clos­er look at an­ti­com­pet­i­tive prac­tices by phar­ma in re­cent years, with the FTC hav­ing a heav­ier hand in merg­ers, and law­mak­ers tak­ing a clos­er look at the mis­use of the patent sys­tem.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER